Market Research Logo

MediPoint: Biosurgery - Global Analysis and Market Forecast

MediPoint: Biosurgery - Global Analysis and Market Forecast

Summary

Prompt hemostasis, effective incision closure, tissue and vessel sealing, and post-operative adhesion prevention have been paramount concerns for surgeons for decades. As medical technology advances, the surgeon’s toolbox expands to include more effective products that actively cease bleeding, close external and internal ruptures in tissue, and provide physical barriers between tissues to prevent dangerous adhesions. These biosurgery products have become indispensable keystones in any operating room environment.

Biosurgery products are experiencing steady growth across many countries. Emerging markets are expected to demonstrate the highest growth among the 15 market covered in the report, which are the US, Canada, Mexico, France, Germany, Italy, Spain, Russia, UK, Japan, China, India, South Korea, Australia, and Brazil.

The taxonomy of biosurgery included in this report covers hemostats, tissue sealants, tissue adhesives, and surgical adhesion barriers.

The global biosurgery market features two main players: J&J and Baxter. Other prominent players include CryoLife, Sanofi, Pfizer, Integra LifeSciences, C.R. Bard, and B. Braun.

The entire market will be driven by aging populations, higher volumes of surgical procedures, and an increasing number of technological innovations.

Key Opinion Leaders emphasize the need for better mechanical properties, optimal biocompatibility, and need for less expensive products.

Highlights

Key Questions Answered

  • What is the current and future biosurgery market outlook in the developed and emerging markets? What trends are affecting the global market?
  • Which are the key, high growth sectors of interest? Which markets segments are growing the fastest?
  • What are the unmet needs with biosurgery products currently on the market? How will future developments fulfill these unmet needs?
  • What are the physician perception s of biosurgery products?
  • What are the challenges that have hindered widespread adoption?
  • How will emerging trends and changing market landscapes affect the future of this space?
Key Findings
  • Emerging economies are seeing the highest growth in the global biosurgery market.
  • Hemostats and tissue sealants make up the largest portions of the market in many countries because they are widely used in a variety of different surgical specialties.
  • The most successful firms involved in biosurgery are providing comprehensive portfolios, undertaking key M&A’s, fostering innovation, and focusing wisely on emerging markets to stay competitive.
  • Rising numbers of different surgical procedures are the primary drivers of the biosurgery market. Despite respectable adoption, unmet needs and non-clinical barriers remain a challenge.
Scope
  • Overview of different hemostats, sealants, adhesives, and adhesion prevention products available to surgeons.
  • Annualized total biosurgery market revenue by segment and market outlooks by country through 2022.
  • Key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access, and implications of the emerging technologies on the market.
  • Analysis of the current and future market competition in the biosurgery market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
Reasons to buy

The report will enable you to -
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global biosurgery market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific markets from 2013-2022.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Market Access
3.1 Reimbursement
3.2 Regulation
3.2.1 North America
3.2.2 Europe
3.2.3 Asia-Pacific
3.3 Key Mergers, Acquisitions, Deals, and Partnerships
4 Unmet Needs
4.1 Overview
4.2 Optimal Mechanical Properties
4.3 Preparation and Storage
4.4 Safety Concerns
4.5 Better Biocompatibility
4.6 Emergency and Military Use of Hemostats
5 Competitive Assessment
5.1 Company Share Analysis
5.1.1 Global Overview
5.1.2 North America
5.1.3 Europe
5.1.4 Asia-Pacific
5.2 Major Players
5.2.1 Advanced Medical Solutions
5.2.2 B. Braun
5.2.3 Atrium Medical
5.2.4 Baxter
5.2.5 C.R. Bard
5.2.6 CryoLife
5.2.7 Gelita
5.2.8 Sanofi
5.2.9 Integra LifeSciences
5.2.10 Ethicon Endo-Surgery (Johnson & Johnson)
5.2.11 Medtronic
5.2.12 Pfizer
5.2.13 Stryker
5.2.14 Takeda
5.3 Emerging Players
5.3.1 3-D Matrix Medical Technology
5.3.2 Adhezion Biomedical
5.3.3 Anika Therapeutics
5.3.4 BioActive Polymers
5.3.5 Chemence Medical
5.3.6 Cohera Medical
5.3.7 Gecko Biomedical
5.3.8 Hemostasis, LLC
5.3.9 HyperBranch Medical Technology
5.3.10 Mallinckrodt
5.3.11 Mast Biosurgery
5.3.12 OptMed
5.3.13 Sealantis
5.3.14 Vivostat
5.4 Distributors
6 Market Outlooks
6.1 Market Drivers and Barriers
6.1.1 Driver: Growing Surgery Markets
6.1.2 Driver: Curtailing the Impact of Excessive Blood Loss
6.1.3 Driver: The Multi-functionality of Fibrin
6.1.4 Driver: Novel Materials and Advanced Features
6.1.5 Barrier: Growth of Laparoscopic Procedures
6.1.6 Barrier: Mechanical Wound Closure Devices
6.1.7 Barrier: Coagulation and Tissue Sealing Using Surgical Energy
6.1.8 Barrier: Steep Costs
6.1.9 Barrier: Regulatory Problems
6.2 Market Outlooks by Segment
6.2.1 Global Overview
6.2.2 Hemostats
6.2.3 Tissue Sealants
6.2.4 Tissue Adhesives
6.2.5 Surgical Adhesion Barriers
6.3 Market Outlooks by Geography
6.3.1 Global Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia-Pacific
6.3.5 South America (Brazil)
6.4 Segment Share by Country
6.4.1 US
6.4.2 Canada
6.4.3 Mexico
6.4.4 France
6.4.5 Germany
6.4.6 Italy
6.4.7 Russia
6.4.8 Spain
6.4.9 UK
6.4.10 Australia
6.4.11 China
6.4.12 India
6.4.13 Japan
6.4.14 South Korea
6.4.15 Brazil
7 Appendix
7.1 Bibliography
7.2 Abbreviations
7.3 Methodology
7.3.1 Overview
7.3.2 Coverage
7.3.3 Secondary Research
7.4 Forecasting Methodology
7.5 Primary Research Efforts
7.6 About the Authors
7.6.1 Shashank Settipalli, Analyst, Medical Devices
7.6.2 Linda Tian, Msc, Managing Analyst, Medical Devices
7.6.3 David Brady, Director of Operations - Market Research
7.6.4 Tyler Fletcher, Global Head of Medical Devices
7.7 About GlobalData
7.8 Disclaimer
1.1 List of Tables
Table 1: Sample HCPCS Codes for Biosurgery Products
Table 2: Recent FDA Approvals and Clearances of Biosurgery Products
Table 3: Key Deals in the Biosurgery Space (2013-2016)
Table 4: Advanced Medical Solutions Company Profile
Table 5: Advanced Medical Solutions SWOT Analysis, 2016
Table 6: Key Marketed Products from Advanced Medical Solutions
Table 7: B. Braun Company Profile
Table 8: B. Braun SWOT Analysis, 2016
Table 9: Key Marketed Products from B. Braun
Table 10: Atrium Medical Company Profile
Table 11: Getinge SWOT Analysis, 2016
Table 12: Key Marketed Products from Atrium Medical
Table 13: Baxter Company Profile
Table 14: Baxter SWOT Analysis, 2016
Table 15: Key Marketed Products from Baxter
Table 16: C.R. Bard Company Profile
Table 17: C.R. Bard SWOT Analysis, 2016
Table 18: Key Marketed Products from C.R. Bard
Table 19: CryoLife Company Profile
Table 20: CryoLife SWOT Analysis, 2016
Table 21: Key Marketed Products from CryoLife
Table 22: Gelita Company Profile
Table 23: Gelita SWOT Analysis, 2016
Table 24: Key Marketed Products from Gelita
Table 25: Sanofi Company Profile
Table 26: Sanofi SWOT Analysis, 2016
Table 27: Key Marketed Products from Sanofi
Table 28: Integra LifeSciences Company Profile
Table 29: Integra LifeSciences SWOT Analysis, 2016
Table 30: Key Marketed Products from Integra Lifesciences
Table 31: Ethicon Company Profile
Table 32: Ethicon SWOT Analysis, 2016
Table 33: Key Marketed Products from Ethicon
Table 34: Medtronic Company Profile
Table 35: Medtronic SWOT Analysis, 2016
Table 36: Key Marketed Products from Medtronic
Table 37: Pfizer Company Profile
Table 38: Pfizer SWOT Analysis, 2016
Table 39: Key Marketed Products from Pfizer
Table 40: Stryker Company Profile
Table 41: Stryker SWOT Analysis, 2016
Table 42: Key Marketed Products from Stryker
Table 43: Takeda Company Profile
Table 44: Takeda SWOT Analysis, 2016
Table 45: Key Marketed Products from Takeda
Table 46: 3-D Matrix Medical Technology Company Profile
Table 47: 3-D Matrix Medical Technology SWOT Analysis, 2016
Table 48: Key Marketed Products from 3-D Matrix Medical Technology
Table 49: Adhezion Biomedical Company Profile
Table 50: Key Marketed Products from Adhezion Biomedical
Table 51: Anika Therapeutics Company Profile
Table 52: Key Marketed Products from Anika Therapeutics
Table 53: BioActive Polymers Company Profile
Table 54: Key Pipeline Products from BioActive Polymers
Table 55: Chemence Medical Company Profile
Table 56: Key Marketed Products from Chemence Medical
Table 57: Cohera Medical Company Profile
Table 58: Key Marketed Products from Advanced Medical Solutions
Table 59: Gecko Biomedical Company Profile
Table 60: Hemostasis Company Profile
Table 61: Key Marketed Products from Hemostasis
Table 62: HyperBranch Company Profile
Table 63: Key Marketed Products from Hemostasis
Table 64: Mallinckrodt Company Profile
Table 65: Key Marketed Products from Mallinckrodt
Table 66: Mast Biosurgery Company Profile
Table 67: Key Marketed Products from Mast Biosurgery
Table 68: OptMed Company Profile
Table 69: Key Marketed Products from OptMed
Table 70: Sealantis Company Profile
Table 71: Key Marketed Products from Sealantis
Table 72: Vivostat Company Profile
Table 73: Major Distributors of Biosurgery Products
Table 74: Global Market Value Forecast by Segment for Biosurgery, $m, 2013-2022
Table 75: North America Market Value Forecast by Segment for Hemostats, $m, 2013-2022
Table 76: Europe Market Value Forecast by Segment for Hemostats, $m, 2013-2022
Table 77: Asia-Pacific Market Value Forecast by Segment for Hemostats, $m, 2013-2022
Table 78: Brazil Market Value Forecast by Segment for Hemostats, $m, 2013-2022
Table 79: North America Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
Table 80: Europe Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
Table 81: Asia-Pacific Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
Table 82: Brazil Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
Table 83: North America Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
Table 84: Europe Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
Table 85: Asia-Pacific Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
Table 86: Brazil Market Value Forecast by Segment for Tissue Sealants, $m, 2013-2022
Table 87: North America Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022
Table 88 : Europe Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022
Table 89 : Asia-Pacific Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022
Table 90 : Brazil Market Value Forecast by Segment for Surgical Adhesion Barriers, $m, 2013-2022
Table 91 : Global Market Value Forecast by Country for Biosurgery, $m, 2013-2022
1.2 List of Figures
Figure 1: Global Company Market Share for Biosurgery, 2015
Figure 2: North America Company Market Share for Biosurgery, 2015
Figure 3: Europe Company Market Share for Biosurgery, 2015
Figure 4: Global Market Forecast for Biosurgery by Segment, 2013-2022
Figure 5: Global Market Forecast for Hemostats by Segment, 2013-2022
Figure 6: North America Market Forecast for Hemostats by Segment, 2013-2022
Figure 7: Europe Market Forecast for Hemostats by Segment, 2013-2022
Figure 8: Asia-Pacific Market Forecast for Hemostats by Segment, 2013-2022
Figure 9: Brazil Market Forecast for Hemostats by Segment, 2013-2022
Figure 10: Global Market Forecast for Tissue Sealants by Segment, 2013-2022
Figure 11: North America Market Forecast for Tissue Sealants by Segment, 2013-2022
Figure 12: Europe Market Forecast for Tissue Sealants by Segment, 2013-2022
Figure 13: Asia-Pacific Market Forecast for Tissue Sealants by Segment, 2013-2022
Figure 14: Brazil Market Forecast for Tissue Sealants by Segment, 2013-2022
Figure 15: Global Market Forecast for Tissue Adhesives by Segment, 2013-2022
Figure 16: North America Market Forecast for Tissue Adhesives by Segment, 2013-2022
Figure 17: Europe Market Forecast for Tissue Adhesives by Segment, 2013-2022
Figure 18: Asia-Pacific Market Forecast for Tissue Adhesives by Segment, 2013-2022
Figure 19: Brazil Market Forecast for Tissue Adhesives by Segment, 2013-2022
Figure 20: Global Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
Figure 21: North America Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
Figure 22: Europe Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
Figure 23: Asia-Pacific Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
Figure 24: Brazil Market Forecast for Surgical Adhesion Barriers by Segment, 2013-2022
Figure 25: Global Market Forecast for Biosurgery by Country, 2013-2022
Figure 26: Global Biosurgery Market Comparison by Country, 2015 and 2022
Figure 27: Global Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
Figure 28: Global Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
Figure 29: Global Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
Figure 30: North America Market Forecast for Biosurgery by Country, 2013-2022
Figure 31: North America Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
Figure 32: North America Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
Figure 33: North America Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
Figure 34: Europe Market Forecast for Biosurgery by Country, 2013-2022
Figure 35: Europe Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
Figure 36: Europe Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
Figure 37: Europe Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
Figure 38: Asia-Pacific Market Forecast for Biosurgery by Country, 2013-2022
Figure 39: Asia-Pacific Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
Figure 40: Asia-Pacific Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
Figure 41: Asia-Pacific Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
Figure 42: Brazil Market Forecast for Biosurgery by Country, 2013-2022
Figure 43: Brazil Sales Volume Forecast for Tissue Sealants by Procedure Type, 2013-2022
Figure 44: Brazil Sales Volume Forecast for Tissue Adhesives by Procedure Type, 2013-2022
Figure 45: Brazil Sales Volume Forecast for Surgical Adhesion Barriers by Procedure Type, 2013-2022
Figure 46: US Biosurgery Market Share by Segment, 2015
Figure 47: Canada Biosurgery Market Share by Segment, 2015
Figure 48: Mexico Biosurgery Market Share by Segment, 2015
Figure 49: France Biosurgery Market Share by Segment, 2015
Figure 50: Germany Biosurgery Market Share by Segment, 2015
Figure 51: Italy Biosurgery Market Share by Segment, 2015
Figure 52: Russia Biosurgery Market Share by Segment, 2015
Figure 53: Spain Biosurgery Market Share by Segment, 2015
Figure 54: UK Biosurgery Market Share by Segment, 2015
Figure 55: Australia Biosurgery Market Share by Segment, 2015
Figure 56: China Biosurgery Market Share by Segment, 2015
Figure 57: India Biosurgery Market Share by Segment, 2015
Figure 58: Japan Biosurgery Market Share by Segment, 2015
Figure 59: South Korea Biosurgery Market Share by Segment, 2015
Figure 60: Brazil Biosurgery Market Share by Segment, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report